QuantBio7 real time PCR instruments for testing Carbapenem Resistant Organism. Currently used real time PCR platform for testing of Carbapenem…

Fisher Scientific Company LLC has been awarded contract HHSTX-6-0000395429 by the State of Texas to supply QuantBio7 real-time polymerase chain reaction (PCR) instruments for Carbapenem Resistant Organism testing. The award was executed on March 3, 2026. These instruments will serve as a replacement platform for the State's current real-time PCR system, which the incumbent vendor will discontinue by 2030. The QuantBio7 platform has received validation approval and will enable the continuation of Carbapenem Resistant Organism testing in support of the Antimicrobial Resistance Lab Network, with expenditures authorized under the SHARP grant and approved by the Centers for Disease Control and Prevention (CDC).

The contract is classified under UNSPSC category 81101706 (Laboratory equipment maintenance) and NIGP category 93862 (Laboratory Equipment and Accessories, Maintenance and Repair). Specific contract values, cumulative amounts, and the detailed period of performance were not disclosed in the available contract documentation. As a laboratory equipment procurement supporting antimicrobial resistance surveillance activities, the award represents the State of Texas's commitment to maintaining diagnostic testing capability for infectious disease surveillance and public health operations.